Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 12.09% |
| 3 | Consumer Discretionary | 8.79% |
| 4 | Healthcare | 8.71% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Navios Maritime Partners
NMM
$2.24B
| $25.3M | ﹤0.01% |
645,125
+208,893
| +48% | +$8.81M |
|
2452
Acadia Realty Trust
AKR
$2.78B
| $25.2M | ﹤0.01% |
1,204,866
-78,936
| -6% | -$1.79M |
|
|
BGB
2453
Blackstone Strategic Credit 2027 Term Fund
BGB
$505M
| $25.2M | ﹤0.01% |
2,089,528
+296,944
| +17% | +$3.65M |
|
2454
Lemonade
LMND
$4.08B
| $25.2M | ﹤0.01% |
802,275
-2,930
| -0.4% | -$101K |
|
2455
Extreme Networks
EXTR
$3.09B
| $25.2M | ﹤0.01% |
1,905,342
-34,454
| -2% | -$540K |
|
2456
Axcelis
ACLS
$4.1B
| $25.2M | ﹤0.01% |
507,380
+11,897
| +2% | +$752K |
|
2457
SiTime
SITM
$20.7B
| $25.2M | ﹤0.01% |
164,757
-4,564
| -3% | -$876K |
|
2458
CarGurus
CARG
$3.35B
| $25.2M | ﹤0.01% |
863,865
-46,194
| -5% | -$1.62M |
|
2459
Ligand Pharmaceuticals
LGND
$6.42B
| $25.1M | ﹤0.01% |
239,092
+31,230
| +15% | +$3.53M |
|
2460
Invesco Dorsey Wright Industrials Momentum ETF
PRN
$432M
| $25.1M | ﹤0.01% |
182,526
+9,789
| +6% | +$1.48M |
|
2461
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$3.09B
| $25.1M | ﹤0.01% |
1,169,145
-10,104
| -0.9% | -$211K |
|
2462
Sociedad Química y Minera de Chile
SQM
$20.8B
| $25.1M | ﹤0.01% |
631,213
+124,528
| +25% | +$4.99M |
|
2463
JPMorgan BetaBuilders Emerging Markets Equity ETF
BBEM
$841M
| $25.1M | ﹤0.01% |
475,964
+381,554
| +404% | +$20.1M |
|
2464
DNOW Inc
DNOW
$3.01B
| $25M | ﹤0.01% |
1,466,546
+166,335
| +13% | +$2.52M |
|
2465
OFG Bancorp
OFG
$2.2B
| $25M | ﹤0.01% |
624,681
-109,738
| -15% | -$4.6M |
|
2466
Descartes Systems
DSGX
$6.86B
| $25M | ﹤0.01% |
247,725
-21,871
| -8% | -$2.42M |
|
2467
Avantis US Small Cap Equity ETF
AVSC
$3.14B
| $24.9M | ﹤0.01% |
515,345
+118,683
| +30% | +$6.27M |
|
|
CALY
2468
Callaway Golf Company
CALY
$3.04B
| $24.9M | ﹤0.01% |
3,773,596
+101,972
| +3% | +$748K |
|
2469
iShares Core Moderate Allocation ETF
AOM
$1.77B
| $24.9M | ﹤0.01% |
566,367
-532,095
| -48% | -$23.4M |
|
2470
MYR Group
MYRG
$5.14B
| $24.8M | ﹤0.01% |
219,724
+21,740
| +11% | +$2.89M |
|
2471
iShares ESG Aware 1-5 Year USD Corporate Bond ETF
SUSB
$1.3B
| $24.8M | ﹤0.01% |
994,264
-111,446
| -10% | -$2.77M |
|
|
BSJP
2472
DELISTED
Invesco BulletShares 2025 High Yield Corporate Bond ETF
BSJP
| $24.8M | ﹤0.01% |
1,077,728
-39,747
| -4% | -$918K |
|
2473
TripAdvisor
TRIP
$1.26B
| $24.8M | ﹤0.01% |
1,750,594
+699,857
| +67% | +$11M |
|
2474
Resideo Technologies
REZI
$3.67B
| $24.8M | ﹤0.01% |
1,401,250
-141,945
| -9% | -$2.91M |
|
2475
Pacira BioSciences
PCRX
$974M
| $24.8M | ﹤0.01% |
997,606
-107,168
| -10% | -$2.57M |
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 410 new, 3,433 increased, 3,308 reduced and 270 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 410 new positions and closed 270 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.